A Study to Assess the Effects of Itraconazole, Food, and pH on the Drug Levels of BMS-986368 in Healthy Participants
Status:
Recruiting
Trial end date:
2024-06-08
Target enrollment:
Participant gender:
Summary
This 2-part study will evaluate the effect of coadministration of a Cytochrome P450, family
3, subfamily A (CYP3A) inhibitor, itraconazole (Part 1), and a high-fat/high-calorie meal and
a modified gastric pH (Part 2), on the single dose drug levels of BMS-986368 in healthy
participants.